In this paper the use of a computer-controlled photodiode array spectrophotometric detector for the high-performance liquid chromatographic (HPLC) profiling of carboxylic acids in physiological fluids is reported. The ultraviolet spectrum of the flowing eluent is obtained at 6-set intervals and is displayed as the absorbance at 190 nm. A three-dimensional (time versus wavelength versus absorbance) presentation of the HPLC profile facilitates peak identification through ultraviolet spectrum matching and relative retention time comparison with carboxylic acid standards. Several rxamples of HPLC urinary csrboxylic acid profiles from infants with various inborn errors of metabolism are shown.
INTRODUCTION
The high-performance liquid chromatographic (HPLC) profiling of carboxylic acids in physiological fluids is a means of distinguishing normal and abnormal specimens as a first approach to the detection of inborn errors of metabolism [1, 2] . The on-column injection of filtered raw urine or plasma to which has been added an internal standard results in fast analyses with minimal sample preparation. The major drawback to this procedure is the lack of a means of peak identification. Both the single- [2] and the dual-column [l] profiling techniques result in most of the carboxylic acids eluting in the first 6-18 min. Thus, most of the acids of interest have similar elution volumes and are hard to identify by peak augmentation. Wavelength ratioing may facilitate peak identification but generally requires one or more additional passes through the HPLC system. Use of a computer-controlled photodiode array spectrophotometer as an HPLC detector affords the UV spectra of each peak as it elutes. Through the use of appropriate software (see Experimental), the UV spectrum and its 1st and 2nd derivatives [3] can be obtained for any peak or portion of a peak, i.e. leading edge, apex or trailing edge. In addition, a three- CA, U.S.A.) in series with a 15-cm, 5 pm particle size, ODS column (Bio-Rad Labs.) with a mobile phase of sulfuric acid pH 2.5. The HP 85 data disk was formated to accept 1000 records while the HP 1040 A detector was set to detect and save all spectra from 190-350 nm at a 0.80 min peak width. The monitor wavelength was 190 nm and the attenuation was 0.2 a.u.f.s. for a lo-p1 injection.
Fraction collection was accomplished by injecting either 0.50 ml or 1.00 ml of urine while the detector was set at 2.5 a.u.f.s. The-volume injected depended upon the creatinine concentration of the urine sample. Urine samples with a creatinine concentration from 0.25 to 1.00 mg/ml required a l.OO-ml aliquot to be injected onto the HPLC columns while samples with a creatinine concentration >l.OO mg/ml required a 0.50-ml aliquot. Fraction collection and GC-MS analysis of samples having a creatinine concentration < 0.20 mg/ml were unsuccessful.
During the first part of the run, fractions were collected at 1-min intervals (6-22 min) while 3-min intervals were used for the duration of the run (23-75 min). Each fraction was rechromatographed (10 ~1 injected; 0.1 a.u.f.s., 0.80 min peak width) to determine the number of components present. A three-dimensional profile (elution time versus wavelength versus absorbance) and the UV spectrum and its 1st and 2nd derivative spectra were produced for each peak in each fraction. Each fraction was saturated with sodium chloride and extracted twice with 3 ml of ethyl acetate and once with 3 ml of diethyl ether. The combined organic extracts were taken to dryness under a stream of air and converted to the trimethylsilyl (TMS) derivative by the addition of 30 ~1 of N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS) and heating for 15 min at 90°C. A l-p1 sample was injected into the GC-MS system.
The GC parameters were: flow-rate: 25 ml/min; injector temperature: 250°C; initial temperature: 90°C; temperature hold: 4 min; final temperature: 280°C; rate of heating: 5"C/min; final temperature hold: 15 min. An electronimpact (EI) mass spectrum was taken for each peak and identification was by comparison of spectra from known standards and from published spectra of TMS carboxylic acid derivatives [4 3 .
RESULTS AND DISCUSSION
A chromatogram for an abnormal urine sample is shown in Fig. 1 . Most of the peaks are found within the first 22 min of the run. Abnormally large peaks are observed at 8,12 and 14 min but their identity cannot be ascertained by reference to the relative retention time (RRT) alone. Using the threedimensional display capability ( Fig. 2A-C ) of the software, we can both separate the peaks by varying the time axis and tentatively identify some of them. The peaks at 12 and 14 min are thought to be lactic acid and succinic acid, respectively, based on their UV spectra. Lactic acid is frequently detected in all patients while the succinic acid is probably of bacterial origin [4] .
The peak at 8.2 min has the correct RRT and UV spectrum for erotic acid. Orotic acid is normally a minor component of urine but is markedly elevated in urea cycle defects [5] . The UV spectrum of the 8.2-min peak and its 1st and 2nd derivative spectra (Fig. 2D ) match that of authentic erotic acid. Other components identified in the chromatogram include the 17.9%min peak which was shown by its UV spectrum to be uric acid [1, 2] and the 67.91-min peak which was thought to be hippuric acid by comparison of its UV spectra with that of authentic hippuric acid. Usually, the UV spectrum of a peak does not exactly match that of any of the standard acids which elute at the same RRT. This was thought to be due to the simultaneous elution of two or more compounds. In order to confirm this, we collected fractions at l-min intervals for the first 22 min of the profile and at 3-min intervals for the duration of the run. Each fraction was converted to the TMS derivative and analyzed by GC-MS. Our initial attempt was unsuccessful. However, when a larger volume of urine was analyzed (0.5-1.0 ml), fraction collection and derivatization were successful. The injection volume necessary for fraction collection was dependent upon the creatinine concentration of the urine (see Experimental), Table I shows the results of fraction collection. As would be expected, there is some overlap between fractions. Since each fraction must be extracted and derivatized, it was expected that not every peak (irrespective of its size in the 190-nm chromatogram) could be identified by GC-MS analysis. The erotic acid and uric acid peaks are good examples since they both have strong absorptivity at 190 nm but were not identified by GC-MS analysis while the uracil peak (20.9 min) was identified by GC-MS. Perhaps the use of a non-extractive isolation technique such as silicic acid absorption [6] or Extrelut columns [7] and the use of a capillary GC column might improve the GC-MS analysis of collected fractions.
Coeluting compounds may not be detectable by UV analysis because of the vast differences in their molar absorptivities. Glutaric acid and pyroglutamic acid were found to coelute with uric acid (Table I ) but were not observed in the UV spectrum of this peak. Coeluting compounds may also escape UV detection when they have the same or similar UV spectrum. The 67.91-min peak of Fig. 1 has the expected RRT and UV spectrum for either hippuric acid or 4-hydroxyphenylacetic acid and cannot be positively identified by its UV spectrum. GC-MS analysis of this peak (Table I) showed that both compounds were present. Fig. 3A shows the 190~nm carboxylic acid profile of a urine sample from an infant with methylmalonic aciduria. The peak at 11.83 min is larger than normal (compare with Fig. 1 ). The three-dimensional plot (Fig. 3B ) and the Oth, 1st and 2nd derivative UV spectra (Fig. 3C ) of this peak indicate that it is methylmalonic acid. The Oth, 1st and 2nd derivative UV spectra of authentic methylmalonic acid are shown in Fig. 3D . The 190~nm urinary carboxylic acid profile shown in Fig. 4A has an abnormally large peak at 8.36 min. Based upon RRT values, this peak could be erotic acid or 2-oxoglutaric acid. The three-dimensional plot of this peak is indicative of a 2-oxocarboxylic acid not erotic acid (compare Fig. 4B with Fig. 2B ), Thus, this peak was identified as 2oxoglutaric acid. CC-MS analysis of the TMS derivatives of the extracted urinary organic acids showed that 2-oxoglutaric acid was indeed elevated. As can be seen by comparing the HPLC carboxylic acid profiles in Pigs. 1, 3A and 4A, there is some day-to-day and run-to-run variation in the elution volume of the compounds. Use of the photodiode array detector to produce the UV spectrum of each peak enables one to identify the internal standard (3-hydroxy4-methoxybenzyl alcohol) and thus calculate the RRT of each peak.
Successful diagnosis and treatment of newborns with catastrophic inborn errors of metabolism requires that the time for analysis be kept to an absolute minimum. A delay in even one or two days may result in irreparable brain damage in the patient while the appropriate therapeutic avenue is sought. Because of the limited sample preparation and the brief (70-80 min) analysis time, we feel that the procedures described in this paper represent a significant advance in the ability to detect certain inborn errors of metabolism. By permitting one to distinguish various carboxylic acids via their UV spectra, it is possible to arrive at a diagnosis of some inborn errors with greater rapidity than was previously possible using GC-MS analysis of the TMS derivatives of the carboxylic acids. Although this procedure does not allow the same amount of information to be obtained as a complete analysis of the TMS-derivatized carboxylic acids via GC-MS, it represents an enhanced first step which can be performed while the more complete analysis is undertaken. In those instances in which information leading to a diagnosis is possible, the delay between diagnosis and institution of appropriate therapy is reduced accordingly.
